Clinical Trial Update: Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating an antioxidant supplement to reduce metachronous colorectal adenomas; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenomas

Drugs mentioned

• Antioxidant supplement

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Colorectal Adenomas | Phase 3 | Status: TERMINATED